Logo image
Integrative analysis of high-throughput cancer studies with contrasted penalization
Journal article   Peer reviewed

Integrative analysis of high-throughput cancer studies with contrasted penalization

Xingjie Shi, Jin Liu, Jian Huang, Yong Zhou, BenChang Shia and Shuangge Ma
Genetic epidemiology, Vol.38(2), pp.144-151
02/2014
DOI: 10.1002/gepi.21781
PMCID: PMC4355402
PMID: 24395534
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4355402View
Open Access

Abstract

In cancer studies with high-throughput genetic and genomic measurements, integrative analysis provides a way to effectively pool and analyze heterogeneous raw data from multiple independent studies and outperforms "classic" meta-analysis and single-dataset analysis. When marker selection is of interest, the genetic basis of multiple datasets can be described using the homogeneity model or the heterogeneity model. In this study, we consider marker selection under the heterogeneity model, which includes the homogeneity model as a special case and can be more flexible. Penalization methods have been developed in the literature for marker selection. This study advances from the published ones by introducing the contrast penalties, which can accommodate the within- and across-dataset structures of covariates/regression coefficients and, by doing so, further improve marker selection performance. Specifically, we develop a penalization method that accommodates the across-dataset structures by smoothing over regression coefficients. An effective iterative algorithm, which calls an inner coordinate descent iteration, is developed. Simulation shows that the proposed method outperforms the benchmark with more accurate marker identification. The analysis of breast cancer and lung cancer prognosis studies with gene expression measurements shows that the proposed method identifies genes different from those using the benchmark and has better prediction performance.
Algorithms Breast Neoplasms - diagnosis Breast Neoplasms - genetics Computer Simulation Female Genetic Markers Humans Lung Neoplasms - diagnosis Lung Neoplasms - genetics Models, Genetic Neoplasms - diagnosis Neoplasms - genetics Prognosis

Details

Metrics

Logo image